News
Important Only
DeFi Technologies Inc - Identifies Share Ownership Imbalances
Aug 12 (Reuters) - DeFi Technologies Inc DEFI.NLB:DEFI TECHNOLOGIES INC - IDENTIFIES SHARE OWNERSHIP IMBALANCESDEFI TECHNOLOGIES INC - REQUESTS RECONCILIATIONS AND EXPLANATIONS FOR SHARE DISCREPANCIESDEFI TECHNOLOGIES INC - COMPANY PREPARED TO ESCALATE MATTER IF RESOLUTIONS UNSATISFACTORYReuters
Tue, Aug 12
Summit Midstream Corporation Reports Second Quarter 2025 Financial Results
Aug 12 (Reuters) - Summit Midstream Corp SMC.N:SUMMIT MIDSTREAM CORPORATION REPORTS SECOND QUARTER 2025 FINANCIAL AND OPERATING RESULTSSUMMIT MIDSTREAM CORP: EXPECT YEAR-END FINANCIAL RESULTS TO BE NEAR LOW END OF ORIGINAL 2025 ADJUSTED EBITDA GUIDANCE RANGE OF $245 MILLION TO $280 MILLIONReuters
Tue, Aug 12
Valvoline Enters First Amendment To Merger Agreement With OC Intermediateco
Aug 12 (Reuters) - Valvoline Inc VVV.N:VALVOLINE INC - ENTERS FIRST AMENDMENT TO MERGER AGREEMENT WITH OC INTERMEDIATECO- SEC FILINGVALVOLINE INC - TERMINATION DATE EXTENDED TO NOVEMBER 15, 2025 - SEC FILINGReuters
Tue, Aug 12
Puretech Health Launches Celea Therapeutics For Respiratory Diseases
Aug 12 (Reuters) - PureTech Health PLC PRTC.L:PURETECH HEALTH PLC - LAUNCHES CELEA THERAPEUTICS FOR RESPIRATORY DISEASESPURETECH HEALTH PLC - SVEN DETHLEFS APPOINTED TO LEAD CELEA THERAPEUTICSPURETECH HEALTH PLC - FDA MEETING ON PHASE 3 TRIAL DESIGN FOR DEUPIRFENIDONE EXPECTED BY Q3 2025Reuters
Tue, Aug 12
Virtus Investment Partners Reports Preliminary July 31 Assets Under Management
Aug 12 (Reuters) - Virtus Investment Partners Inc VRTS.N:VIRTUS INVESTMENT PARTNERS REPORTS PRELIMINARY JULY 31, 2025 ASSETS UNDER MANAGEMENTVIRTUS INVESTMENT PARTNERS INC - REPORTS PRELIMINARY AUM OF $170.8 BILLION AS OF JULY 31, 2025Reuters
Tue, Aug 12
AN2 Therapeutics Commences First-in-Human Clinical Trial of Oral AN2-502998 for Chagas Disease
Aug 12 (Reuters) - AN2 Therapeutics Inc ANTX.O:AN2 THERAPEUTICS COMMENCES FIRST-IN-HUMAN CLINICAL TRIAL OF ORAL AN2-502998 FOR CHAGAS DISEASEAN2 THERAPEUTICS - PHASE 2 PLANNING UNDERWAY WITH DNDI COLLABORATION; INITIATION EXPECTED IN 2026, DATA IN 2027Reuters
Tue, Aug 12
Cardinal Health Adds Solaris Health To Specialty Alliance
Aug 12 (Reuters) - Cardinal Health Inc CAH.N:CARDINAL HEALTH INC - ADDS SOLARIS HEALTH TO SPECIALTY ALLIANCECARDINAL HEALTH INC - DEAL EXPECTED TO BE ACCRETIVE TO EPS IN FIRST YEARCARDINAL HEALTH INC - PROVIDES $1.9 BILLION IN CASH TO THE SPECIALTY ALLIANCE FOR ACQUISITIONCARDINAL HEALTH INC - EXPEC...Reuters
Tue, Aug 12
Canada's CIBC shakes up leadership ranks ahead of CEO transition
Aug 12 (Reuters) - Canadian lender CIBC CM.TO reshuffled its executive team on Tuesday, as it prepares for incoming Chief Executive Officer Harry Culham to take the helm in November.The bank named Christian Exshaw its group head of capital markets, home to its crucial investment banking arm. It also...Reuters
Tue, Aug 12
CORRECTED-Liquidia reports Q2 revenue of $8.8 mln, net loss widens
OverviewLiquidia reports Q2 revenue of $8.8 mln following YUTREPIA launchNet loss for Q2 widens to $41.6 mln due to commercialization costsCo reports positive interim ASCENT trial data for YUTREPIAOutlookLiquidia plans to expand market access for YUTREPIA in Q3 and Q4Company aims to scale YUTREPIA a...Reuters
Tue, Aug 12
Morning News Call - Canada, August 12
To access a PDF version of this newsletter, please click hereYou can read Morning News Call Canada via TOPNEWS Canada page.If you would like to receive this newsletter through your email, please register at:https://solutions.lseg.com/MorningNewsCallEN-subscription-pageECONOMIC EVENTS0830 Building pe...Reuters
Tue, Aug 12
TIMELINE-Trump's trade war: Tariff deadlines and key upcoming events
August 12 (Reuters) - The twists and turns in U.S. President Donald Trump's tariff policies have not only roiled global financial markets but also taken investors on a roller-coaster ride.Adding to the uncertainty are tariff-related legal challenges and Trump's assertion that he will hammer ...Reuters
Tue, Aug 12
Industrial materials supplier Neo's Q2 revenue beats expectations, raises full-year EBITDA guidance
OverviewNeo Q2 revenue rises to $114.7 mln, beating analyst expectationsAdjusted EBITDA up 42% yr/yr, driven by strong operational performanceCompany raises full-year 2025 adjusted EBITDA guidance to $64-$68 mlnOutlookNeo raises full-year 2025 Adjusted EBITDA guidance to $64.0-$68.0 mlnCompany expec...Reuters
Tue, Aug 12
Shopee-owner Sea beats quarterly revenue estimates
Aug 12 (Reuters) - Shopee-owner Sea Ltd SE.N topped market estimates for quarterly revenue on Tuesday, powered by strong growth at its e-commerce business, while its financial services and entertainment segments also saw robust demand.
Reuters
Tue, Aug 12
Canada's Rogers Sugar beats Q3 revenue estimates
OverviewRogers Sugar fiscal Q3 revenue rises to C$313.8 mln, beating analyst expectationsAdjusted EBITDA for fiscal Q3 increases to C$36.6 mln, driven by Sugar segmentCo progressing with LEAP Project to expand sugar refining capacity in MontréalOutlookCompany anticipates sugar sales volume of 785,00...Reuters
Tue, Aug 12
Beasley Broadcast Group's Q2 revenue falls on ad softness, sales execution challenges
OverviewBeasley Q2 revenue falls 12.3% yr/yr to $53.0 mlnAdjusted EBITDA drops to $4.7 mln from $8.8 mln in prior-year periodSays top-line impacted by advertising softness and ongoing sales execution challengesOutlookBeasley launching new self-serve platform in Q3Result DriversADVERTISING SOFTNESS -...Reuters
Tue, Aug 12
Clean tech equipment maker Broadwind's Q2 revenue beats expectations
OverviewBroadwind Q2 revenue rises 7.6% y/y, beating analyst expectationsCompany reports Q2 net loss of $1.0 mln, adjusted EBITDA at $2.1 mlnCo announces pending sale of Manitowoc operations, adding $13 mln to balance sheetOutlookBroadwind suspends full-year 2025 guidance due to pending Manitowoc sa...Reuters
Tue, Aug 12
Xtant Medical Q2 revenue up 18%, raises FY25 guidance
OverviewXtant Medical Q2 revenue rises 18% yr/yr to $35.4 mlnNet income for Q2 totals $3.6 mln, reversing prior year lossCompany raises FY25 revenue guidanceOutlookXtant raises FY25 revenue guidance to $131-$135 mlnCompany anticipates 11%-15% revenue growth over FY24Xtant plans to update outlook pos...Reuters
Tue, Aug 12
Apparel company Unisync's Q3 revenue rises
OverviewUnisync Q3 FY2025 revenue rises to C$21.9 mln, driven by UGL segmentPretax profit improves to C$1.8 mln, reflecting disciplined cost managementUnisync Group Limited (UGL) segment margins surge to 23.5%, aided by operational efficienciesOutlookUnisync expects improved UGL margins from lower i...Reuters
Tue, Aug 12
